An inside job: Subversion of the host secretory pathway by intestinal pathogens

Current Opinion in Infectious Diseases

Volumn 23, Issue 5, 2010, Pages 464-469

  Sharp, Tyler M ^a   Estes, Mary K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

E. coli; enterovirus; norovirus; rotavirus; secretory pathway

Indexed keywords

ADENOVIRUS; CELL MEMBRANE; CELL VACUOLE; ENDOPLASMIC RETICULUM; ENTEROVIRUS; ESCHERICHIA COLI INFECTION; GOLGI COMPLEX; HUMAN; INTESTINE FLORA; MEMBRANE DAMAGE; NONHUMAN; NOROVIRUS; PATHOGENESIS; REVIEW; ROTAVIRUS; SECRETORY VESICLE; VIRUS INFECTION;

ENTEROCYTES; ESCHERICHIA COLI; HOST-PATHOGEN INTERACTIONS; HUMANS; NOROVIRUS; PICORNAVIRIDAE; PROTEIN TRANSPORT; ROTAVIRUS; SECRETORY PATHWAY; VIRULENCE FACTORS;

EID: 77956217089     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32833dcebd     Document Type: Review

References (68)

1. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 2003; 81:197-204.
2. Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. EID 1999; 5:607-625.
3. Herikstad H, Yang S, Van Gilder TJ, et al. A population-based estimate of the burden of diarrhoeal illness in the United States: FoodNet, 1996-7. Epidemiol Infect 2002; 129:9-17.
4. Vembar SS, Brodsky JL One step at a time: endoplasmic reticulum-asso-ciated degradation. Nat Rev Mol Cell Biol 2008; 9:944-957.
5. Hutt DM, Powers ET, Balch WE. The proteostasis boundary in misfolding diseases of membrane traffic. FEBS Lett 2009; 583:2639-2646.
6. Venkatasubramanian J, Ao M, Rao MC. Ion transport in the small intestine. Curr Opin Gastroenterol 2010; 26:123-128.
7. Chardin P, McCormick F. Brefeldin A: the advantage of being uncompetitive. Cell 1999; 97:153-155.
8. Girod A, Storrie B, Simpson JC, et al. Evidence for a COP-I-independent transport route from the Golgi complex to the endoplasmic reticulum. Nature Cell Biol 1999; 1:423-430.
9. Johannes L, Romer W. Shiga toxins: from cell biology to biomedical applications. Nat Rev Microbiol 2010; 8:105-116.
10. Pierini R, Cottam E, Roberts R, Wileman T. Modulation of membrane traffic between endoplasmic reticulum, ERGIC and Golgi to generate compartments for the replication of bacteria and viruses. Semin Cell Dev Biol 2009;20:828-833.
11. Roy CR. Bacterial subversion of the host secretory pathway. Proc Natl Acad Sci USA 2005; 102:1271-1272.
12. Roy CR, Salcedo SP, Gorvel JP. Pathogen-endoplasmic-reticulum interactions: in through the out door. Nat Rev Immunol 2006; 6:136-147.
13. Kim J, Thanabalasuriar A, Chaworth-Musters T, et al. The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function. Cell Host Microbe 2007; 2:160-171.
14. Thanabalasuriar A, Koutsouris A, Weflen A, et al. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli. Cell Microbiol 2010; 12:31-41.
15. Laiko M, Murtazina R, Malyukova I, et al. Shiga toxin 1 interaction with enterocytes causes apical protein mistargeting through the depletion of intracellular galectin-3. Exp Cell Res 2010; 316:657-666.
16. Fernandez-Vega V, Sosnovtsev SV, Belliot G, et al. Norwalk virus N-terminal nonstructural protein is associated with disassembly of the Golgi complex in transfected cells. J Virol 2004; 78:4827-4837.
17. Ettayebi K, Hardy ME. Norwalk virus nonstructural protein p48 forms a complex with the SNARE regulator VAP-A and prevents cell surface expression of vesicular stomatitis virus G protein. J Virol 2003; 77:11790-11797.
18. Xu A, Bellamy AR, Taylor JA. Immobilization of the early secretory pathway by a virus glycoprotein that binds to microtubules. EMBO J 2000; 19:6465-6474.
19. Wessels E, Duijsings D, Lanke KHW, et al. Effects of picornavirus3A proteins on protein transport and GBF1-dependent COP-I recruitment. J Virol 2006; 80:11852-11860.
20. Wessels E, Duijsings D, NiuTK, et al. A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. Dev Cell 2006; 11:191-201.
21. Cornell CT, Kiosses WB, HarkinsS, Whitton JL. Inhibition of protein trafficking by coxsackievirus B3: multiple viral proteins target a single organelle. J Virol 2006; 80:6637-6647.
22. MadanV, Sanchez-Martinez S,Vedovato N, etal. Plasma membrane-porating domain in poliovirus2B protein. A short peptide mimics viroporin activity. J Mol Biol 2007; 374:951-964.
23. Nieva JL, Agirre A, Nir S, Carrasco L. Mechanisms of membrane permeabi-lization by picornavirus 2B viroporin. FEBS Lett 2003; 552:68-73.
24. Sanchez-Martinez S, Huarte N, Maeso R, et al. Functional and structural characterization of 2B viroporin membranolytic domains. Biochem 2008; 47:10731-10739.
25. Robert A, Smadja-Lamere N, Landry MC, et al. Adenovirus E4orf4 hijacks rho GTPase-dependent actin dynamics to kill cells: a role for endosome-asso-ciated actin assembly. Mol Biol Cell 2006; 17:3329-3344.
26. Landry MC, Sicotte A, Champagne C, Lavoie JN. Regulation of cell death by recycling endosomes and golgi membrane dynamics via a pathway involving Src-family kinases, Cdc42 and Rab11a. Mol Biol Cell 2009; 20:4091-4106.
27. DuPont HL. Systematic review: the epidemiology and clinical features of travellers' diarrhoea. Aliment Pharmacol Ther 2009; 30:187-196.
28. Centers for Disease Control and Prevention (CDC). Enterotoxigenic Escher-ichia coli (ETEC). 2010. Internet Communication: http://www.cdc.gov/ nczved/divisions/dfbmd/diseases/enterotoxigenic-ecoli/
29. Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escher-ichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 2005; 18:465-483.
30. Gruenheid S, Sekirov I, Thomas NA, et al. Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohae-morrhagic Escherichia coli O157: H7. Mol Microbiol 2004; 51:1233-1249.
31. Roe AJ, Tysall L, Dransfield T, et al. Analysis of the expression, regulation and export of NleA-E in Escherichia coli O157: H7. Microbiol 2007; 153:1350-1360.
32. Creuzburg K, Schmidt H. Molecular characterization and distribution of genes encoding members of the type III effector nleA family among pathogenic Escherichia coli strains. J Clin Microbiol 2007; 45:2498-2507.
33. Coombes BK, Wickham ME, Mascarenhas M, et al. Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains. Appl Environ Microbiol 2008; 74:2153-2160.
34. Mundy R, Petrovska L, Smollett K, et al. Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect Immun 2004; 72:2288-2302.
35. Barbieri L, Valbonesi P, Brigotti M, et al. Shiga-like toxin I is a polynucleo-tide:adenosine glycosidase. Mol Microbiol 1998; 29:661-662.
36. Brigotti M, Alfieri R, Sestili P, et al. Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells. FASEB J 2002; 16:365-372.
37. Friedrich AW, Zhang W, Bielaszewska M, et al. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Clin Infect Dis 2007; 45:39-45.
38. Schmidt H, Karch H. Enterohemolytic phenotypes and genotypes of shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome. J Clin Microbiol 1996; 34:2364-2367.
39. Muthing J, Schweppe CH, Karch H, Friedrich AW. Shiga toxins, glycosphin-golipid diversity, and endothelial cell injury. Thromb Haemost 2009; 101:252-264.
40. Schmidt H. Shiga-toxin-converting bacteriophages. Res Microbiol 2001; 152:687-695.
41. Allison HE. Stx-phages: drivers and mediators of the evolution of STEC and STEC-like pathogens. Future Microbiol 2007; 2:165-174.
42. Creuzburg K, Recktenwald J, Kuhle V, et al. The Shiga toxin 1-converting bacteriophage BP-4795 encodes an NleA-like type III effector protein. J Bacteriol 2005; 187:8494-8498.
43. Doedens JR, Kirkegaard K. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J 1995; 14:894-907.
44. Doedens JR, Giddings TH, Kirkegaard K. Inhibition of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: genetic and ultrastructural analysis. J Virol 1997; 71:9054-9064.
45. Beske O, Reichelt M, Taylor MP, et al. Poliovirus infection blocks ERGIC-to-Golgi trafficking and induces microtubule-dependent disruption of the Golgi complex. J Cell Sci 2007; 120:3207-3218.
46. Deitz SB, Dodd DA, Cooper S, et al. MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A. Proc Natl Acad Sci\USA 2000; 97:13790-13795.
47. Neznanov N, Kondratova A, Chumakov KM, et al. Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from cell surface. J Virol 2001; 75:10409-10420.
48. Dodd DA, Giddings TH, Kirkegaard K. Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection. J Virol 2001; 75:8158-8165.
49. Choe SS, Dodd DA, Kirkegaard K. Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology 2005; 337:18-29.
50. Wessels E, Duijsings D, Lanke KHW, et al. Molecular determinants of the interaction between coxsackievirus protein 3A and guanine nucleotide exchange factor GBF1. J Virol 2007; 81:5238-5245.
51. Agirre A, Barco A, Carrasco L, Nieva JL. Viroporin-mediated membrane permeabilization: pore formation by nonstructural poliovirus 2B protein. J Biol Chem 2002; 277:40434-40441.
52. Corbett EF, Michalak M. Calcium, a signaling molecule in the endoplasmic reticulum? Trends Biochem Sci 2000; 25:307-311.
53. Missiaen L, Dode L, Vanoevelen J, et al. Calcium in the Golgi apparatus. Cell Calcium 2007; 41:405-416.
54. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12:304-306.
55. Jourdan N, Maurice M, Delautier D, et al. Rotavirus is released from the apical surface of cultured human intestinal cells through nonconventional vesicular transport that bypasses the Golgi apparatus. J Virol 1997; 71: 8268-8278.
56. Zhang M, Zeng CQ, Morris AP, Estes MK. A functional NSP4 enterotoxin peptide secreted from rotavirus-infected cells. J Virol 2000; 74:11663-11670.
57. Beau I, Berger A, Servin AL. Rotavirus impairs the biosynthesis of brush-border-associated dipeptidyl peptidase IV in human enterocyte-like Caco-2/TC7 cells. Cell Microbiol 2007; 9:779-789.
58. Jourdan N, Brunet JP, Sapin C, et al. Rotavirus infection reduces sucrase-isomaltase expression in human intestinal epithelial cells by perturbing protein targeting and organization of microvillar cytoskeleton. J Virol 1998; 72:7228-7236.
59. Rodriguez LS, Barreto A, Franco MA, Angel J. Immunomodulators released during rotavirus infection of polarized caco-2 cells. Viral Immunol 2009; 22:163-172.
60. Ball JM, Mitchell DM, Gibbons TF, Parr RD. Rotavirus NSP4: a multifunctional viral enterotoxin. Viral Immunol 2005; 18:27-40.
61. Ball JM, Tian P, Zeng CQ, et al. Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 1996; 272:101-104.
62. Greenberg HB, Estes MK. Rotaviruses: from pathogenesis to vaccination. Gastroenterology 2009; 136:1939-1951.
63. Glass RI, Parashar U, Estes MK. Norovirus gastroenteritis. N Engl J Med 2009; 361:50-59.
64. Atmar RL, Estes MK. The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am 2006; 35:275-290; viii.
65. Patel MM, Widdowson MA, Glass RI, etal. Systematic literature review of role of norovirusesinsporadic gastroenteritis.Emerg InfectDis2008;14:1224-1231.
66. Young KT, Davis LM, Dirita VJ. Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol 2007; 5:665-679.
67. Krajden M, Brown M, Petrasek A, Middleton PJ. Clinical features of adenovirus enteritis: a review of 127 cases. Pediatr Infect Dis J 1990; 9:636-641.
68. De Jong JC. Epidemiology of enteric adenoviruses 40 and 41 and other radenoviruses in immunocompetent and immunodeficient individuals. In: Desselberger U, Gray J, editors. Viral Gastroenteritis. Amsterdam: Elsevier Science; 2003. pp. 407-445.